Wolverine Trading’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Wolverine Trading’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-11,000	Closed	-$198K	–	5488
2020 Q2	$198K	Sell	11,000 -40,300	-79%	-$561K	﹤0.01%	3835
2020 Q1	$373K	Buy	51,300 +13,400	+35%	+$167K	﹤0.01%	2981
2019 Q4	$904K	Buy	37,900 +16,900	+80%	+$466K	﹤0.01%	2510
2019 Q3	$563K	Sell	21,000 -11,000	-34%	-$309K	﹤0.01%	2512
2019 Q2	$868K	Buy	32,000 +1,800	+6%	+$56.4K	﹤0.01%	2177
2019 Q1	$1.05M	Sell	30,200 -37,500	-55%	-$1.08M	﹤0.01%	2031
2018 Q4	$1.16M	Buy	67,700 +27,600	+69%	+$568K	﹤0.01%	1846
2018 Q3	$1.07M	Buy	+40,100	New	+$1.31M	﹤0.01%	2288

Wolverine Trading's PTLA Position: Q2 2020 in Review

Wolverine Trading sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q2 2020, closing a stake of 40,332 shares — an estimated $561K sold.

Wolverine Trading first reported a position in PTLA in Q3 2018 and held it in 7 quarters. The position peaked at $1.07M in Q1 2019. 162 funds tracked by Wall St. Rank hold PTLA as of Q2 2020.

Wolverine Trading reported no remaining Portola Pharmaceuticals, Inc. position as of Q2 2020 after selling out during the quarter.
Wolverine Trading sold 40,332 Portola Pharmaceuticals, Inc. shares in Q2 2020, an estimated $561K.
Wolverine Trading first reported a position in Portola Pharmaceuticals, Inc. in Q3 2018 and held it in 7 quarters.
Wolverine Trading's Portola Pharmaceuticals, Inc. position peaked at $1.07M in Q1 2019.
162 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q2 2020.

Based on Wolverine Trading's 13F filing for Q2 2020, filed 13 Aug 2020.